03.13.15
St. Paul, Minn.-based 3M has acquired Ivera Medical Corp., a manufacturer of healthcare products that disinfect and protect devices used for access into a patient’s bloodstream. The business is now a wholly owned subsidiary of 3M and a part of its Critical & Chronic Care Solutions Division.
3M’s vascular access products play an important role in helping to reduce complications for patients with intravenous (IV) catheters. The addition of Ivera will enable 3M to bring a broader array of vascular access solutions to more healthcare systems worldwide.
Ivera’s IV port connector caps, sold under the Curos brand, are used to disinfect and act as a barrier to contamination on devices that provide access to IV lines. These products complement 3M’s vascular access products including Tegaderm CHG (Chlorhexidine Gluconate) IV Securement Dressings, which deliver the critical elements of antimicrobial protection and securement for IV site care.
Ivera is based in San Diego, Calif., employs approximately 60 people and has annual sales of approximately $30 million.
3M is a science-based company with a diverse array of products.
3M’s vascular access products play an important role in helping to reduce complications for patients with intravenous (IV) catheters. The addition of Ivera will enable 3M to bring a broader array of vascular access solutions to more healthcare systems worldwide.
Ivera’s IV port connector caps, sold under the Curos brand, are used to disinfect and act as a barrier to contamination on devices that provide access to IV lines. These products complement 3M’s vascular access products including Tegaderm CHG (Chlorhexidine Gluconate) IV Securement Dressings, which deliver the critical elements of antimicrobial protection and securement for IV site care.
Ivera is based in San Diego, Calif., employs approximately 60 people and has annual sales of approximately $30 million.
3M is a science-based company with a diverse array of products.